Inhibition of MurA Enzyme from by Flavonoids and Their Synthetic Analogues

Overview

Journal ACS Omega

Publisher American Chemical Society

Specialty Chemistry

Date 2023 Sep 18

PMID 37720776

Authors

Rok Frlan

Martina Hrast

Stanislav Gobec

Affiliations

Soon will be listed here.

Abstract

MurA catalyzes the first step of peptidoglycan (PG) biosynthesis and is a validated target for the development of new antimicrobial agents. In this study, a library of 49 plant flavonoids and their synthetic derivatives were evaluated for their inhibitory properties against MurA from. The compounds were tested with and without preincubation and with the addition of DTT to understand the mechanism of inhibition. Thirteen compounds were identified as reversible, time-dependent inhibitors, with inhibition levels ranging from 480 nM to 57 μM, and ampelopsin as the most potent compound. To investigate the major pharmacophore elements responsible for the activity, 2D-QSAR and docking analyzes were performed. The results showed that the catechol moiety and an additional aromatic system were the most important features contributing to the activity of the compounds. However, most of the compounds did not show antibacterial activity against andstrains, suggesting that their inhibitory activity against MurA may not be strong enough to induce antibacterial effects. Nevertheless, our results suggest that flavonoids are a promising starting point to develop new inhibitors of MurA and show great potential for further steps in drug development.

Citing Articles

Biophysical characterization and in silico analysis of natural and synthetic compounds targeting Listeria monocytogenes HtrA protease.

Amrutha M, Wessler S, Ponnuraj K Mol Divers. 2024; .

PMID: 39604603 DOI: 10.1007/s11030-024-11050-0.

References

Zhang F, Graham J, Zhai T, Liu Y, Huang Z . Discovery of MurA Inhibitors as Novel Antimicrobials through an Integrated Computational and Experimental Approach. Antibiotics (Basel). 2022; 11(4). PMC: 9031695. DOI: 10.3390/antibiotics11040528. View

Kaushal N, Singh M, Singh Sangwan R . Flavonoids: Food associations, therapeutic mechanisms, metabolism and nanoformulations. Food Res Int. 2022; 157:111442. DOI: 10.1016/j.foodres.2022.111442. View

Darby E, Trampari E, Siasat P, Gaya M, Alav I, Webber M . Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 2022; 21(5):280-295. DOI: 10.1038/s41579-022-00820-y. View

Lolli G, Cozza G, Mazzorana M, Tibaldi E, Cesaro L, Donella-Deana A . Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight. Biochemistry. 2012; 51(31):6097-107. DOI: 10.1021/bi300531c. View

Kurnia D, Apriyanti E, Soraya C, Satari M . Antibacterial Flavonoids Against Oral Bacteria of Enterococcus Faecalis ATCC 29212 from Sarang Semut (Myrmecodia pendans) and Its Inhibitor Activity Against Enzyme MurA. Curr Drug Discov Technol. 2018; 16(3):290-296. DOI: 10.2174/1570163815666180828113920. View

Tao S, Chen H, Li N, Liang W . The Application of the CRISPR-Cas System in Antibiotic Resistance. Infect Drug Resist. 2022; 15:4155-4168. PMC: 9356603. DOI: 10.2147/IDR.S370869. View

Lim J, Ferruzzi M, Hamaker B . Structural requirements of flavonoids for the selective inhibition of α-amylase versus α-glucosidase. Food Chem. 2021; 370:130981. DOI: 10.1016/j.foodchem.2021.130981. View

OBoyle N, Banck M, James C, Morley C, Vandermeersch T, Hutchison G . Open Babel: An open chemical toolbox. J Cheminform. 2011; 3:33. PMC: 3198950. DOI: 10.1186/1758-2946-3-33. View

Shelley J, Cholleti A, Frye L, Greenwood J, Timlin M, Uchimaya M . Epik: a software program for pK( a ) prediction and protonation state generation for drug-like molecules. J Comput Aided Mol Des. 2007; 21(12):681-91. DOI: 10.1007/s10822-007-9133-z. View

10.

Zhu K, Borrelli K, Greenwood J, Day T, Abel R, Farid R . Docking covalent inhibitors: a parameter free approach to pose prediction and scoring. J Chem Inf Model. 2014; 54(7):1932-40. DOI: 10.1021/ci500118s. View

11.

Atanasov A, Zotchev S, Dirsch V, Supuran C . Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021; 20(3):200-216. PMC: 7841765. DOI: 10.1038/s41573-020-00114-z. View

12.

Lindahl M, Tagesson C . Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2. Inflammation. 1997; 21(3):347-56. DOI: 10.1023/a:1027306118026. View

13.

Kajiya K, Hojo H, Suzuki M, Nanjo F, Kumazawa S, Nakayama T . Relationship between antibacterial activity of (+)-catechin derivatives and their interaction with a model membrane. J Agric Food Chem. 2004; 52(6):1514-9. DOI: 10.1021/jf0350111. View

14.

Lv P, Li H, Xue J, Shi L, Zhu H . Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents. Eur J Med Chem. 2008; 44(2):908-14. DOI: 10.1016/j.ejmech.2008.01.013. View

15.

Dutta S, Basak A, Dasgupta S . Synthesis and ribonuclease A inhibition activity of resorcinol and phloroglucinol derivatives of catechin and epicatechin: Importance of hydroxyl groups. Bioorg Med Chem. 2010; 18(17):6538-46. DOI: 10.1016/j.bmc.2010.06.077. View

16.

Proj M, Hrast M, Bajc G, Frlan R, Meden A, Butala M . Discovery of a fragment hit compound targeting D-Ala:D-Ala ligase of bacterial peptidoglycan biosynthesis. J Enzyme Inhib Med Chem. 2022; 38(1):387-397. PMC: 9718554. DOI: 10.1080/14756366.2022.2149745. View

17.

Kumar A, Saranathan R, Prashanth K, Tiwary B, Krishna R . Inhibition of the MurA enzyme in Fusobacterium nucleatum by potential inhibitors identified through computational and in vitro approaches. Mol Biosyst. 2017; 13(5):939-954. DOI: 10.1039/c7mb00074j. View

18.

Gautam A, Vyas R, Tewari R . Peptidoglycan biosynthesis machinery: a rich source of drug targets. Crit Rev Biotechnol. 2010; 31(4):295-336. DOI: 10.3109/07388551.2010.525498. View

19.

Lanzetta P, Alvarez L, Reinach P, Candia O . An improved assay for nanomole amounts of inorganic phosphate. Anal Biochem. 1979; 100(1):95-7. DOI: 10.1016/0003-2697(79)90115-5. View

20.

Ertl P, Rohde B, Selzer P . Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem. 2000; 43(20):3714-7. DOI: 10.1021/jm000942e. View